Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-08-20

Clinical Trial Update: Effect of Bifidobacterium on Irritable Bowel Syndrome [NA]

View source ↗

Summary

The document describes a clinical trial assessing the effect of the probiotic Bifidobacterium on irritable bowel syndrome. The status is listed as UNKNOWN, and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bifidobacterium (Bifidobacterium)

Snippet

Sponsor: Tohoku University | Conditions: Irritable Bowel Syndrome | NA | Status: UNKNOWN